Use of hepatitis B surface and “e” antigen quantification during extensive treatment with tenofovir in patients co‐infected with HIV‐HBV

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|3|795-804

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.3, 2015-03, pp. : 795-804

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Occult hepatitis B in HIV-HCV coinfected patients

By Piroth Lionel   Lafon Marie-Edith   Binquet Christine   Bertillon Pascale   Gervais Anne   Lootvoet Enguerrand   Lang Jean-Marie   Jaureguiberry Jean   Chene Genevieve   Leport Catherine  

Scandinavian Journal of Infectious Diseases, Vol. 40, Iss. 10, 2008-01 ,pp. : 835-839

Informa Healthcare

Access to resources Recommend Favorite

Acute and chronic immune biomarker changes during interferon/ribavirin treatment in HIV/HCV co‐infected patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 1, 2015-01 ,pp. : 25-36

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Significance of Hepatitis B Surface Antigen in Cord Blood of Hepatitis B e-Antigen-Negative Chronic Hepatitis B Virus-Infected Mothers

By  

Intervirology, Vol. 52, Iss. 3, 2009-05 ,pp. : 132-134

Karger

Access to resources Recommend Favorite

Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 1, 2018-01 ,pp. : 38-49

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tenofovir in the treatment of chronic hepatitis B

By Yu Derek   Heathcote Jenny  

Therapy, Vol. 8, Iss. 5, 2011-09 ,pp. : 527-544

Future Medicine

Access to resources Recommend Favorite